Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02310776 · ClinicalTrials.gov registry record · NA
Lesion Detection of Automated Breast Ultrasound Compared With Handheld Physician-performed Breast Ultrasound
A NA study of Breast Diseases, sponsored by Northwestern University.
- Completed
- Registry status
- NA
- Development phase
- 501
- Enrollment target
- 2
- Study locations
NCT02310776 is a NA study of Breast Diseases that has completed, run by Northwestern University. The registered enrollment target is 501 participants, above the 255-participant average among 8 other Breast Diseases trials with a reported enrollment target (96% higher). The trial reports 2 study locations across 2 states.
The verdict
NCT02310776, a NA study of Breast Diseases, has completed, sponsored by Northwestern University.
- COMPLETED
- Registry status
- NA
- Development phase
- 501 participants
- Enrollment target
- 2
- Study locations
Study Summary
Compare lesion detection of the automated breast ultrasound (ABVS) exam with the conventional handheld (HH) breast ultrasound (US) exam.
Conditions Studied
Interventions
- DEVICE Supine automated breast ultrasound scanner
- DEVICE High-resolution handheld breast ultrasound
Study Locations (2)
Illinois
- Northwestern Medicine - Chicago
Pennsylvania
- Weinstein Imaging - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 501 participants |
| Start Date | 2012-06 |
| Est. Completion | 2015-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02310776
The ClinicalTrials.gov registry entry for NCT02310776 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 501 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 255-participant average among 8 other Breast Diseases trials with a reported enrollment target (96% higher). The listed sponsor is Northwestern University, which has 1,209 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Breast Diseases appearing as the primary indexed condition, and to 2 interventions - of which Supine automated breast ultrasound scanner is the first listed.
NCT02310776 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Illinois, Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT02310776 about?
NCT02310776 is a clinical study titled "Lesion Detection of Automated Breast Ultrasound Compared With Handheld Physician-performed Breast Ultrasound". Compare lesion detection of the automated breast ultrasound (ABVS) exam with the conventional handheld (HH) breast ultrasound (US) exam.
What is the current status of trial NCT02310776?
This trial is currently completed. It is a NA study. The enrollment target is 501 participants. The study started on 2012-06. Estimated completion is 2015-10.
What conditions does trial NCT02310776 study?
This clinical trial studies the following conditions: Breast Diseases.
What interventions are being tested in trial NCT02310776?
The interventions under investigation include: Supine automated breast ultrasound scanner (DEVICE), High-resolution handheld breast ultrasound (DEVICE).
Who is sponsoring clinical trial NCT02310776?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02310776 being conducted?
This trial has 2 study locations across Illinois, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Diseases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Focal Breast Pain: Does a Normal Ultrasound Provide Reassurance?
COMPLETED · NA
-
Study of Abemaciclib and Elacestrant in Participants With Brain Metastasis Due to ER+/HER-2- Breast Cancer
RECRUITING · Phase 1
-
A Study of Breast Cancer Risk Factors and Outcomes of People in Florida
RECRUITING
-
Studying the Effect of Denosumab on Preventing Breast Cancer in Women With a BRCA1 Germline Mutation
ACTIVE NOT RECRUITING · Phase 3
-
Anastrozole, Palbociclib, Trastuzumab and Pertuzumab in HR-positive, HER2-positive Metastatic Breast
ACTIVE NOT RECRUITING · Phase 1
-
Abbreviate or FAST Breast MRI for Supplemental Breast Cancer Screening for Black Women at Average Risk and Dense Breasts
ACTIVE NOT RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.